Myasthenia Gravis Treatment Market, by Drug class Thumbnail Image

2023

Myasthenia Gravis Treatment Market, by Drug class

Myasthenia Gravis Treatment Market, by Drug class (Monoclonal antibodies, Intravenous immunoglobulin, Others), by Age group (Below 55 years, Above 55 years), by Distribution channel (Hospital pharmacies, Drug store and retail pharmacies, Online providers): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Pharmaceuticals

  • Apr 2023

  • Pages: 263

  • Tables: 117

  • Charts: 67

Select an option
Cloud Access (30% Off) $3,570 $2,499
Business User License (30% Off) $5,730 $4,011
Enterprise License (30% Off) $9,600 $6,720
Library Membership (15% Off) $1,175 $999
Request Free Sample
Author's: Shraddha Mali | Roshan Deshmukh
Publish Date:
Enquire Before Buying Update on Demand Speak with Analyst